Losartan for Patients With COVID-19 Requiring Hospitalization
Status:
Completed
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, double-blinded study of COVID-19 infected patients requiring
inpatient hospital admission randomized 1:1 to daily Losartan or placebo for 7 days or
hospital discharge.